Abstract
Intracerebroventricular application of low, nondiabetogenic doses (500 micrograms kg-1) of alloxan and streptozocin is followed by alterations of the dopaminergic system in rat striatum. In this brain region the dopamine content significantly increased, while the density of dopaminergic D1 receptors significantly decreased seven days after the intracerebroventricular application of betacytotoxics, as compared with the control group. The density of dopaminergic D2 receptors in striatum remained unchanged. Dopaminergic D1 and D2 receptors operate through signalling mechanism of G proteins, but no changes of Gs and Gi proteins content have been found in rat striatum after the intracerebroventricular application of betacytotoxics. As intracerebroventricular, nondiabetogenic administration of betacytotoxics produces changes of the striatal dopamine content and D1 receptor density similar to that produced by peripheral, diabetogenic administration of these drugs, the effect might be related not solely to pancreatic beta cells damage, but to alterations of the brain insulin system, as well.
References
Jan 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A DingS Hoyer
Sep 1, 1992·Diabetes·M Salković, Z Lacković
Nov 1, 1992·Neurobiology of Aging·H SoininenP J Riekkinen
Dec 1, 1992·Molecular and Chemical Neuropathology·C FincoA Gorio
May 1, 1992·Diabetes·A L McCall
Jan 1, 1990·Life Sciences·Z Lacković, M Salković
Feb 22, 1991·Biochimica Et Biophysica Acta·C LivingstoneM D Houslay
Oct 21, 1991·Biochimica Et Biophysica Acta·T M Palmer, M D Houslay
Sep 13, 1990·Nature·P SokoloffJ C Schwartz
Jan 1, 1990·Journal of Neurochemistry·Z LackovićM Relja
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W F SimondsA M Spiegel
Dec 1, 1989·Journal of Neuroscience Research·M P AbbracchioA Gorio
May 21, 1987·Nature·D GawlerM D Houslay
Apr 27, 1988·European Journal of Pharmacology·M HadjiconstantinouN H Neff
Dec 1, 1988·Endocrinology·Y ShimomuraS Kobayashi
Jan 1, 1987·Annual Review of Physiology·D G BaskinD M Dorsa
Feb 1, 1967·Life Sciences·E P NobleJ Axelrod
Oct 30, 1984·European Journal of Pharmacology·D W SchulzR B Mailman
May 1, 1983·Journal of Neurochemistry·M E Trulson, C D Himmel
Nov 27, 1981·Science·D LozovskyI J Kopin
Jan 14, 1994·Brain Research·T Kono, M Takada
Nov 1, 1993·Trends in Pharmacological Sciences·G Milligan
Citations
May 30, 2001·Molecular and Cellular Endocrinology·W Q Zhao, D L Alkon
Jan 18, 2006·Journal of Neurochemistry·Melita Salkovic-PetrisicPeter Riederer
Apr 24, 2007·Journal of Neurochemistry·Edna GrünblattSiegfried Hoyer
Jul 10, 2013·Addiction Biology·Laura E O'DellArbi Nazarian
Aug 26, 2003·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R F MacedoJ A R Gontijo
Dec 7, 2002·Hypertension·Dhananjay N UmraniMustafa F Lokhandwala
Mar 27, 2015·Journal of Neural Transmission·Ana KnezovicMelita Salkovic-Petrisic
Feb 8, 2020·Journal of Neural Transmission·Jelena Osmanovic BarilarMelita Salkovic-Petrisic
Jul 3, 2007·Neurochemical Research·Ismet TahirovicPeter Riederer
Jan 6, 2000·Life Sciences·K MardonA Donald
Oct 23, 2017·Neuroscience Research·Zohreh AbbasiMasoud Fereidoni